Xeris Biopharma Holdings, Inc. (XERS)

CIK 1867096 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Xeris Biopharma Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001867096-26-000114
Nov 5, 20261440001950047-26-010752
Nov 5, 202610-Q0001867096-26-000117
Nov 4, 202630001867096-26-000103
Nov 4, 202640001867096-26-000107
Nov 4, 202640001867096-26-000109
Nov 4, 202640001867096-26-000111
Nov 4, 202640001867096-26-000105
Nov 2, 20268-K0001867096-26-000095
Nov 2, 20261440001950047-26-010584
Oct 30, 2026SCHEDULE 13G/A0002100119-26-001642
Oct 14, 20268-K0001867096-26-000091
Oct 2, 202640001867096-26-000085
Oct 2, 202640001867096-26-000086
Oct 2, 202640001867096-26-000084
Oct 1, 20261440001950047-26-009959
Sep 29, 202640001867096-26-000078
Sep 28, 20261440001950047-26-009839
Sep 9, 20268-K0001867096-26-000077
Sep 1, 202640002031695-26-000011
Sep 1, 202640001652410-26-000018
Sep 1, 202640001875714-26-000012
Aug 21, 202640001867096-26-000073
Aug 21, 202640001867096-26-000069
Aug 12, 202640001875714-26-000009